Clinical trials
Waldenstrom Macroglobulinemia trials in Australia
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
20 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2006 | 1 |
| 2007 | 1 |
| 2013 | 3 |
| 2014 | 1 |
| 2017 | 2 |
| 2019 | 1 |
| 2021 | 5 |
| 2022 | 1 |
| 2023 | 1 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 6 |
| Recruiting | 5 |
| Active, not recruiting | 4 |
| Terminated | 2 |
| Withdrawn | 2 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| BeOne Medicines | 2 |
| Gilead Sciences | 2 |
| Ascentage Pharma Group Inc. | 1 |
| BeiGene | 1 |
| Cellectar Biosciences, Inc. | 1 |
| Eli Lilly and Company | 1 |
| Hutchmed | 1 |
| Janssen Research & Development, LLC | 1 |
| Jonsson Comprehensive Cancer Center | 1 |
| Loxo Oncology, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Waldenstrom Macroglobulinemia | 20 |
| Lymphoma, B-Cell, Marginal Zone | 12 |
| Lymphoma, Follicular | 11 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 10 |
| Lymphoma, Mantle-Cell | 10 |
| Lymphoma, Non-Hodgkin | 9 |
| Lymphoma | 7 |
| Lymphoma, Large B-Cell, Diffuse | 7 |
| Lymphoma, B-Cell | 4 |
| Dendritic Cell Sarcoma, Interdigitating | 3 |
Trials
Showing 76 to 20 of 20. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.